Malaysia nghiên cứu phát triển 2 loại vaccine ngừa COVID-19
Ngày 13/6, Bộ trưởng Y tế Malaysia Adham Baba cho biết êkíp nghiên cứu khoa học của Viện Nghiên cứu y dược (IMR) thuộc Bộ Y tế đang nỗ lực nghiên cứu phát triển 2 loại vaccine ngừa COVID-19. Ông Baba cho biết thêm trong 2 loại vaccine được IMR nghiên cứu phát triển có 1 loại là vaccine mRNA và 1 loại là vaccine bất hoạt.
9fx5975x6dafx86e4x8586xb1c5x89f8x5945x2e4xX7x634ax4b1axeb2x716dx3258x13a1xX5x440exXax96eex673cxX6xX5xX6x4ac1xX7xXdxX6xX3xaa65xa058xX1xXdx26b8xX1cxX3xX4x8a3x6436xX3xXbxX1x8b3xXexX3xXex5e3bxXdx96e2xX1cxX3xb102xX3xX5x7ddcx391axXdxX3xb7bbxX6xX4xX4xXdxX1cxX10xX3xX1cxX1dx9bf4xX6xX3x33e5x93b4x8aeaxc3ex2236x94a6xX2xc7dxX0x2eafxX1xX2xX12xX0xXbxX3xX4xX5xX6xX7xX7xX9xXaxXbxfccxX10xX6x34dbxXaxX12x8619xX1dx10f5xX17xX3xX2x2e5xX4fxb14xa989xX3x2240x2838xX3xXexX2dx784ex3994xX1cxX1dxX3x2a34xX3xXex40d9xX3xX13xX6xX5xX6xX17xX7xXdxX6xX3xa0dexX61xX1xX6x1377xX3xX6fxX6x2e3axX6xX3xX4xX1xX35xX3xX8fxXdxX7cxXexX3xX20x34b4x1eb7xXbxX3xX1cxX1dxX1xXdxX20xX1cxX3xX4xX24xX25xX3xX9cxX1xX35xX6xX3xX1x31e0xX4xX3xX4x2f7xX6xX3xX48xXdxb879xX1cxX3xX64xX1dxX1xXdxX20xX1cxX3xX4xX24xX25xX3xX17xX3xX61xX74x89dfxX4xX3x64a9xX49xX13x9724xa44axX3xXexX1xX25xX70xX4xX3xX6fxX70xX3xX79xX3xXexX7cxX3x7d07xX6xX1cxX1dxX3xX1cx612cxX3xX5x7b71xX4xX3xX1cxX1dxX1xXdxX20xX1cxX3xX4xX24xX25xX3xXbxX1xX29xXexX3xXexX2dxXdxX2fxX1cxX3xX32xX3xX5xX35xX36xXdxX3xX39xX6xX4xX4xXdxX1cxX10xX3xX1cxX1dxX43xX6xX3xX46xX47xX48xX49xX4axX4bxX2xX4dx35d8xX3x613dxX1cxX1dxX3xX6fxX6xX8fxX6xX3xX4xX1xX35xX3xX8fxXdxX7cxXexX3xXexX1xX20xX8bxX3xXexX2dxX35xX1cxX1dxX3xX32xX3xX5xX35xX36xXdxX3xX39xX6xX4xX4xXdxX1cxX10xX3xXe3xX74xXccxX4xX3xX49xX13xXd2xX3xX1cxX1dxX1xXdxX20xX1cxX3xX4xX24xX25xX3xXbxX1xX29xXexX3xXexX2dxXdxX2fxX1cxX3xX4x2ee7xX3xX2xX3xX5xX35xX36xXdxX3xX5xX66xX3xX39xX6xX4xX4xXdxX1cxX10xX3xX8bxXd2xX64xX87xX3xX39xX66xX3xX2xX3xX5xX35xX36xXdxX3xX5xX66xX3xX39xX6xX4xX4xXdxX1cxX10xX3xX8fx2155xXexX3xX1xX35xX36xXexX121xX0xX4fxXbxX12xX0xXbxX3xX4xX5xX6xX7xX7xX9xXaxXbxX6fxX35xX61xX17xXaxX12xX0xXdxX8bxX1dxX3xX4xX5xX6xX7xX7xX9xXaxX4xX8bxX7xX4bxXbxX1xX35xXexX35xXaxX3xXexXdxXexX5xX10xX9xXaxX13xX6xX5xX6xX17xX7xXdxX6xX3xX1cxX1dxX1xXdxX20xX1cxX3xX4xX24xX25xX3xXbxX1xX29xXexX3xXexX2dxXdxX2fxX1cxX3xX32xX3xX5xX35xX36xXdxX3xX39xX6xX4xX4xXdxX1cxX10xX3xX1cxX1dxX43xX6xX3xX46xX47xX48xX49xX4axX4bxX2xX4dxX3xX1x233exX1cxX1xX3x1d5axX1cxX1xX3xX2xXaxX3xX7xX2dxX4xX9xXaxX4fxX4fxXdxX121xX8fxX6xX35xXexX1xX6xX1cxX1xX1xX35xX6xX121xX39xX1cxX4fxX1cxX10x9f49xX7xX4fxX32xX2xX32x7a42xX4fxX2xa8a7xX244xX61xX2xa2d6xb2a8xX6axX32xX241xX241xXexX244xX248xX32xX2xX5xX2xX121x20d0xXbxX1dxXaxX3xX6xX5xXexX9xXaxX13xX6xX5xX6xX17xX7xXdxX6xX3xX1cxX1dxX1xXdxX20xX1cxX3xX4xX24xX25xX3xXbxX1xX29xXexX3xXexX2dxXdxX2fxX1cxX3xX32xX3xX5xX35xX36xXdxX3xX39xX6xX4xX4xXdxX1cxX10xX3xX1cxX1dxX43xX6xX3xX46xX47xX48xX49xX4axX4bxX2xX4dxXaxX3xX61xX6xXexX6xX4bxXbxX1xX35xXexX35xX4bxX35xX2dxXdxX1dxXdxX1cxX6xX5xX4bxX7xX2dxX4xX9xXaxX1xXexXexXbxX7x8669xX4fxX4fxX4xX61xX1cxXdxX8bxX1dxX121xX39xXdxX10xXexX1cxX6xX8bxXbxX5xX25xX7xX121xX39xX1cxX4fxXexX6cxX32xX248xX4fxX25xXbxX5xX35xX6xX61xX10xX61xX4fxXdx8bf0xX61xX7xX7xX4fxX32xX248xX32xX2x380dxX248xX6cxX2ecxX2xX6axX4fxX8bxX6xX5xX6xX17xX7xXdxX6xX2ecxX39xX6xX4xX4xXdxX1cxX10xX121xX256xXbxX1dxXaxX3xX4fxX12xX64xX1dxX74x7fefxXdxX3xX61x72f2xX1cxX3xX4xX1xX30exX3xXe3xX74xXccxX4xX3xXexXdxX20xX8bxX3xX39xX6xX4xX4xXdxX1cxX10xX3xX1cxX1dxX43xX6xX3xX46xX47xX48xX49xX4axX4bxX2xX4dxX3xXexX36xXdxX3x7567xX25xX6xX5xX6xX3x1101xX25xX8bxXbxX25xX2dxX6dxX3xX13xX6xX5xX6xX17xX7xXdxX6xX3xX1cxX1dxX66xX17xX3xX6axX2xX4fx16d9xX4fxX32xX248xX32xX2xX121xX3xXcfx13exX1cxX1xX2bbxX3xX87x6395x810exX4fxXcxXcx6608xX48xX64xXd3xX0xX4fxXbxX12xX0xXbxX3xX4xX5xX6xX7xX7xX9xXaxXbxX6fxX35xX61xX17xXaxX12xX4axXecxX3xX29xX1cxX3xX1cxX66xX17xX3xX7x8372xX3xX1dxXdx48axXbxX3xX1cxX312xX1cxX1dxX3xX4xX6xX35xX3xX1cxacfcxX1cxX1dxX3xX5xXecxX4xX3xX1cxX1dxX1xXdxX20xX1cxX3xX4xX24xX25xX3xXbxX1xX29xXexX3xXexX2dxXdxX2fxX1cxX3xX39xX6xX4xX4xXdxX1cxX10xX3xX4xXb5xX6xX3xX13xX6xX5xX6xX17xX7xXdxX6xX6dxX3xXe3x8fecxX1cxX1dxX3xXexX1xX30exXdxX3xX1cxX1x249dxX8bxX3xX4xX1xX25x6c2xX1cxX3xX8fx2caaxX3xX4xX1xX35xX3xX39xXdxXbaxX4xX3xX24xX1cxX1dxX3xXbxX1xX16fxX3xX39x110dxXdxX3xX61xX3efxX4xX1xX3xX8fxXbaxX1cxX1xX3xXexX74xaba6xX1cxX1dxX3xX5xX6xXdxX121xX0xX4fxXbxX12xX0xXbxX3xX4xX5xX6xX7xX7xX9xXaxXbxX6fxX35xX61xX17xXaxX12xXcxX2dxX74xX403xX4xX3xXe3xX16fxX3xX9cxX1xXdxX3xXexX2dxX21axX3xX5xX30exXdxX3xXbxX1x5d9axX1cxX1dxX3xX39xX19exX1cxX3xXexX30exX3x1d9cxXexX25xX7xX6xX1cxX3xX13xX10xX5xX6xX17xX25xX3xX39xX66xX35xX3xX1x91f4xX8bxX3xX2xX32xX4fxX6cxX6dxX3xX464xX1cxX1dxX3xX6fxX6xX8fxX6xX3xX1cxX16fxXdxX3xX2dxX3e5xX1cxX1dxX3xX39xX66xX35xX3xXexX1xX29xX1cxX1dxX3xX249xX4fxX32xX248xX32xX248xX6dxX3xX5exX70xXdxX3xXe3xX3daxX1cxX1dxX3xX33dxX1xX35xX6xX3xX1xXb1xX4xX3x8c7axX25x7e34xX4xX3xX1dxXdxX6xX3xX13xX6xX5xX6xX17xX7xXdxX6xX3xXe3x16f6xX3xXe3x2e3bxXexX3xX8bx98c0xX4xX3xXexXdxX20xX25xX3xXbxX1xX29xXexX3xXexX2dxXdxX2fxX1cxX3xX39xX6xX4xX4xXdxX1cxX10xX6dxX3xX7xX6xX25xX3xXe3xX16fxX3xX8fx41f0xXexX3xXe3x36d7xX25xX3xXexXdxX7cxX1cxX3xX1xX66xX1cxX1xX3xX1cxX1dxX1xXdxX20xX1cxX3xX4xX24xX25xX3xX39xX66xX3xX1cxX312xX1cxX1dxX3xX4xX6xX35xX3xX1cxX3a5xX1cxX1dxX3xX5xXecxX4xX3xX7xX21axX1cxX3x26b6xX25xX19exXexX3xX121xX0xX4fxXbxX12xX0xXbxX3xX4xX5xX6xX7xX7xX9xXaxXbxX6fxX35xX61xX17xXaxX12xX64xX1dxX35xX66xXdxX3xX6fxX70xX3xX79xX3xXexX7cxX6dxX3xX39xXdxXbaxX4xX3xX1cxX1dxX1xXdxX20xX1cxX3xX4xX24xX25xX3xXbxX1xX29xXexX3xXexX2dxXdxX2fxX1cxX3xX39xX6xX4xX4xXdxX1cxX10xX3xX4x9e15xX1cxX3xX4xX16fxX3xX7xXecxX3xXexX1xX6xX8bxX3xX1dxXdxX6xX3xX4xXb5xX6xX3xX6fxX70xX3xX33dxX1xX35xX6xX3xX1xXb1xX4xX3xX46xX464xX1cxX1dxX3xX1cxX1dxX1xXbaxX3xX39xX66xX3xX7xX29xX1cxX1dxX3xXexX36xX35xX3xX4x4580xX1cxX1dxX3xX6fxX70xX3x1cefxXdxX29xX35xX3xX61xX4bdxX4xX3xX8fxa6caxX4xX3xX4xX6xX35xX121xX4fxX121xX0xX4fxXbxX12xX0xXbxX3xX4xX5xX6xX7xX7xX9xXaxXbxX87xX25xXexX1xX35xX2dxXaxX12xXcfxXcxXcxX370xX48xX64xX4fxX48xXdxX10xXexX1cxX6xX8bx16axXd3xX0xX4fxXbxX12
(TTXVN/Vietnam+)